CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (1,446,000,000)	$ (1,349,000,000)
Depreciation and amortization	280,000,000	188,000,000
Stock-based compensation expense	233,000,000	183,000,000
Inventory LCNRV write-downs and losses on firm purchase commitments	150,000,000	229,000,000
Other non-cash activities	53,000,000	2,000,000
Changes in operating assets and liabilities:
Accounts receivable, net	(228,000,000)	(55,000,000)
Inventory	(435,000,000)	(781,000,000)
Other assets	(81,000,000)	(29,000,000)
Accounts payable and accrued liabilities	113,000,000	22,000,000
Other liabilities	92,000,000	69,000,000
Net cash used in operating activities	(1,269,000,000)	(1,521,000,000)
Cash flows from investing activities:
Purchases of short-term investments	(902,000,000)	0
Maturities of short-term investments	550,000,000	0
Capital expenditures	(254,000,000)	(283,000,000)
Net cash used in investing activities	(606,000,000)	(283,000,000)
Cash flows from financing activities:
Proceeds from issuance of capital stock	2,000,000	3,000,000
Proceeds from issuance of convertible notes	0	1,485,000,000
Other financing activities	(4,000,000)	(3,000,000)
Net cash provided by (used in) financing activities	(2,000,000)	1,485,000,000
Effect of exchange rate changes on cash and cash equivalents	(1,000,000)	0
Net change in cash	(1,878,000,000)	(319,000,000)
Cash, cash equivalents, and restricted cash—Beginning of period	7,857,000,000	12,099,000,000
Cash, cash equivalents, and restricted cash—End of period	5,979,000,000	11,780,000,000
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	383,000,000	333,000,000
Capital stock issued to settle bonuses	179,000,000	137,000,000
Right-of-use assets obtained in exchange for operating lease liabilities	$ 52,000,000	$ 11,000,000